The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

According to the Minister, the tool is “an investment in the power of data to save lives. Our political will to end TB is ...

Emphasising the urgent need for continued vigilance and improved access to advanced treatment options, the National TB ...

Cuts to US health aid could cause 2.5 million more child TB cases and 340,000 deaths in low- and middle-income countries by ...

WHO praises Fiji’s commitment to accessible healthcare as the facility consolidates services for faster, seamless treatment.

“Fiji is weaving a stronger fabric of care, one that echoes our regional vision, weaving health for families, communities, ...

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published ...

Led by Joe Fox, professor of chemistry and biochemistry, the fresh funding will enable continued and sustained work at the ...

The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

The emotional strain on parents and other caregivers faced with deciding whether a tracheotomy is the best treatment for ...

An international study led by Jonathon Campbell at The Institute highlights the powerful health and economic impact of ...

Considering the scale and severity of TB in India, it is important to understand the implications of the new WHO guidelines ...